Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Empaglifozin”

4 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 4 of 4 results

Testing effectiveness (Phase 2)UnknownNCT04138251
What this trial is testing

Safety, Efficacy Evaluation of Empagliflozin Administration for Neutropenia in Glycogenosis Type 1b and G6PC3 Deficiency

Who this might be right for
Glycogen Storage Disease Type IGlucose 6 Phosphatase Deficiency
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 5
Early research (Phase 1)Study completedNCT03852901
What this trial is testing

Sodium-glucose Co Transporter 2 (sGLT2) Inhibitor and Endogenous Ketone Production

Who this might be right for
EmpaglifozinPhysiological Effects of DrugsHypoglycemic Agents+1 more
National Institute on Aging (NIA) 21
Large-scale testing (Phase 3)WithdrawnNCT03173963
What this trial is testing

Empaglifozin in Early Diabetic Kidney Disease

Who this might be right for
Diabetic Kidney DiseaseDiabetes Mellitus Type 2
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Post-approval studies (Phase 4)Study completedNCT05359432
What this trial is testing

Comparison of Empaglifozin and Vildagliptin in Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes
Getz Pharma 120